Bibliographic record

Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian…

Mu Y, Bao X, Eliaschewitz FG, Hansen MR, Kim BT, Koroleva A, Ma RCW, Yang T, Zu N, Liu M. The Lancet Diabetes & Endocrinology 2024

Document identifier: CEI-BR-077
Series: Bibliographic record
Version: 1.0
Published: 30 Jul 2026
Last reviewed: 30 Jul 2026
Certainty: Not rated

§1Bibliographic record

§1.1Record

Authors: Mu Y, Bao X, Eliaschewitz FG, Hansen MR, Kim BT, Koroleva A, Ma RCW, Yang T, Zu N, Liu M
Title: Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
Source: The Lancet Diabetes & Endocrinology
Year: 2024
Volume, issue, pages: 12(3):184–195
Digital object identifier: 10.1016/S2213-8587(23)00388-1
PubMed identifier: 38330481
Record type: Journal article
Institute identifier: CEI-BR-077

§1.2Institute documents citing this record

No Institute document currently cites this record. It is held in the bibliography because it was retrieved during a search and assessed, and the Institute records what it assessed and did not use as well as what it used.

§1.3Subject tags

semaglutide china STEP

Compound Evidence Institute · CEI-BR-077 · https://compoundevidence.com/bibliography/mu2024/ · retrieved 30 July 2026